Melanoma sentinel node biopsy and prediction models for relapse and overall survival
Open Access
- 21 September 2010
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 103 (8) , 1229-1236
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 40 references indexed in Scilit:
- A Multimarker Prognostic Assay for Primary Cutaneous MelanomaClinical Cancer Research, 2009
- Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free SurvivalClinical Cancer Research, 2009
- Osteopontin: Role in immune regulation and stress responsesCytokine & Growth Factor Reviews, 2008
- Validation of a Nomogram to Predict the Presence of Sentinel Lymph Node Metastases in MelanomaAnnals of Surgical Oncology, 2008
- High expression of DNA repair pathways is associated with metastasis in melanoma patientsOncogene, 2007
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical OutcomeJNCI: Journal of the National Cancer Institute, 2006
- Osteopontin Expression Correlates with Melanoma InvasionJournal of Investigative Dermatology, 2005
- Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsyBritish Journal of Surgery, 2002
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI: Journal of the National Cancer Institute, 1989